Hyperfractionated Accelerated Radiotherapy for T1,2 Glottic Carcinoma
β Scribed by Koh-ichi Sakata; Masanori Someya; Masakazu Hori; Kensei Nakata; Masaru Takagi; Masato Hareyama
- Publisher
- Springer
- Year
- 2008
- Tongue
- German
- Weight
- 492 KB
- Volume
- 184
- Category
- Article
- ISSN
- 0179-7158
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Because of promising radiobiological advantages allowing dose escalation and/or reduction of treatment time, hyperfractionated and accelerated-hyperfractionated radiotherapy (hf-rt, ahf-rt) were introduced as part of treatment of glioblastoma multiforme (gbm). In December 1988 we started a prospecti
## Abstract ## Background Our aim was to evaluate the efficacy and toxicity of chemoradiotherapy (CRT) with transoral debulking microsurgery for T2N0 glottic cancer. ## Methods Thirty patients with T2N0 glottic cancer treated with concurrent hyperfractionated radiotherapy (RT) and carboplatin we
A series of 478 patients with T,.,No glottic carcinoma treated by irradiation is presented. Of these patients, 320 were previously untreated, whereas 158 patients were referred for treatment of a recurrence after receiving radiotherapy elsewhere. The primary recurrence rate in the previously untreat
## Abstract T1βT2 glottic carcinomas may be treated with conservative surgery or radiotherapy. The goals of treatment are cure and laryngeal voice preservation. The aim of the current study was to review the pertinent literature and discuss the optimal management of earlyβstage laryngeal carcinoma.